The "Rated R" superstar keeps it PG! Check out other cute and candid moments from the stars.
Allison Schmitt Olympic Schedule Kyla Ross Montenegro Olympic Games Dana Vollmer Ryan Dempster
Sunday, July 28, 2013
Lincoln Memorial closed after it is vandalized with green paint
By NBCWashington.com
The Lincoln Memorial will be closed until further notice after green paint was discovered on the monument Friday morning.
A visitor found the paint splattered on the statue and on the floor around it just before 1:30 a.m. and reported it to police. No words or symbols were written on the statue, News4's Megan McGrath reported.
The U.S. Park Police say the monument will reopen once the National Park Service cleans the statue. There's no estimate on when that work will be done, but maintenance crews are expected to arrive Friday morning.
Read original story on NBCWashington.com
Surveillance cameras are located on either corner of the monument. There's no word on whether the cameras captured the vandal.
This is not the first time vandalism has been reported at the site of one of the National Mall's memorials.
Back in 2007, an oily substance was found on the memorial wall of the Vietnam Veterans Memorial. Police determined the case to be an act of vandalism and not an accident,?The Washington Post reported. The removal process took weeks to complete.
Two additional incidents of vandalism have been reported at? Vietnam Veterans Memorial in the past. In 1993, the directory stands at the entrance of the memorial were burned, and a swastika and scratches were found etched in two of the memorials panels in 1988. Both panels were replaced.
Other than those incidents, NPS spokeswoman Carol Johnson said she cannot recall any other cases of vandalism at the National Mall.
The Lincoln Memorial, which was dedicated in 1922, is open to the public 24 hours a day.
lake havasu halo 4 jewel san francisco earthquake san francisco earthquake terminator salvation terminator salvation
Saturday, July 27, 2013
Dispute Between Military, Morsi Supporters Flares In Egypt
Mass demonstrations are expected in Egyptian cities Friday amid fears of an imminent crackdown by security forces on supporters of former President Mohammed Morsi. The military chief who ousted Morsi urged Egyptians to come out in force to give the army a mandate to deal with "violence and terror." Muslim Brotherhood leaders have called for rival protests, after accusing the military chief of calling for civil war.
Source: http://news.wpr.org/post/dispute-between-military-morsi-supporters-flares-egypt
Thanksgiving Day cooking a turkey toysrus how to carve a turkey ipad 2 wal mart happy thanksgiving
Friday, July 26, 2013
Hisense Sero 7 Pro review: a newcomer tries its hand at Android tablets
Hisense, a company best known for its home theater equipment, isn't exactly a name synonymous with mobile devices. But with its new, Walmart-exclusive line of Android tablets -- the Sero 7 LT and Sero 7 Pro -- the Chinese manufacturer is dipping its toe into an increasingly crowded pool. Both tablets occupy the budget end of the spectrum, with the higher-end of the two, the Sero 7 Pro, going for a reasonable $150. For the price, the specs are decent: the Sero comes with a 1,280 x 800 display, a quad-core Tegra 3 processor and Android 4.2 Jelly Bean. We dove headfirst into this bargain buy to see how it fares against similarly priced 7-inch tablets. Want to find out if Hisense has the chops to compete? Read on, friends.
Filed under: Tablets
weather nyc national signing day Solomon Islands Mary Leakey Side Effects bob marley weather
Europe backs new dual-action Novartis lung drug
LONDON (Reuters) - Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro Breezhaler.
Also known as QVA149, the once-daily medicine belongs to a new type of dual-action treatments that are expected by analysts to become major sellers and is the first in the class to win such a green light.
The green light from the European Medicines Agency (EMA) paves the way for full marketing authorization in the next two or three months. Approval in the key U.S. market remains some way off, since the drug will not be filed there until late 2014.
The new product contains two bronchodilators - indacaterol, a long-acting beta2-adrenergic agonist (LABA), and glycopyrronium, a long-acting muscarinic antagonist (LAMA).
Glycopyrronium was licensed from Vectura, entitling the British firm to milestone payments and royalties on sales. Shares in Ventura rose 7 percent on Friday's news.
Other companies including GlaxoSmithKline are also working to develop such LABA/LAMA combinations.
Novartis is banking on new drugs, including QVA149, to fill the gap left by the loss of exclusivity on its blockbuster blood pressure pill Diovan. It also has high hopes for Serelaxin, a treatment for acute heart failure and psoriasis drug AIN457.
QVA149 is designed to treat chronic obstructive pulmonary disease (COPD), a disease that causes breathing trouble and chronic coughing, and is sometimes fatal. It affects an estimated 210 million people worldwide.
Analysts at Berenberg said Ultibro could achieve annual sales of around $2.3 billion by 2021, of which $1.7 billion could be generated outside the United States.
HIV DRUG GREEN LIGHT
The EMA said it had also recommended a new HIV medicine from Gilead Sciences called Tybost, or cobicistat, a drug that does not itself fight the virus that causes AIDS but boosts the function of other HIV medicines.
The European recommendation contrasts with a rebuff for the Gilead product from U.S. regulators in April.
In addition, the EMA issued a positive opinion for Gentium's drug Defitelio for use in patients undergoing blood stem-cell transplantation, and Boehringer Ingelheim's lung cancer drug Giotrif.
GSK's Revolade was recommended for wider use in patients with thrombocytopenia associated with chronic hepatitis C infection, while Bayer's Eylea was backed for wider use in eye disease. Regeneron is Bayer's partner on Eylea.
Otsuka's new drug Delamanid for treating multidrug-resistant tuberculosis, however, was not recommended for approval.
Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.
(Reporting by Ben Hirschler and Caroline Copley.; editing by Keith Weir and Patrick Graham)
Source: http://news.yahoo.com/eu-regulators-back-novartis-inhaler-gilead-hiv-drug-115130901.html
the monkees strikeforce davy jones love actually miesha tate vs ronda rousey idiocracy deep impact
Ex-US commander: ?I paid a military security price? for American support of Israel
Sorry, Readability was unable to parse this page for content.
Source: http://www.redressonline.com/wp-admin/post.php?post=6170&action=edit&message=1
cinco de mayo Mike Jeffries Abercrombie Charles Ramsey Interview Limo Fire Mayweather vs Guerrero Mario Machado May the Fourth be with you
Wednesday, July 24, 2013
India gets its second Boeing Globemaster transport plane
[unable to retrieve full-text content]
Source: news.in.msn.com --- Tuesday, July 23, 2013
Source: http://news.in.msn.com/national/article.aspx?cp-documentid=253423650
Bayern Munich the blaze Michael Shannon Chrissy Amphlett Java stevie wonder 2013 NFL Mock Draft
Subscribe to:
Posts (Atom)